Translate page

  • Presentations from the EHA2022 Congress

  • EHA 2022: Mechanisms of disease progression in chronic myeloid leukemia (S. Tiong Ong)

  • EHA 2022: Non-BCR-ABL1 biomarkers of prognosis in CML (Shady Awad)

  • COLT Meeting 2019: CML related topics

  • COLT Meeting 2019: The CML frontier

    Collage FlaggenYou can view recordings of the 'iCMLf conversations on CML and COVID-19' in non-English languages here.
    Additional conversations in Mandarin, Russian, Spanish and French will be made available over the next couple of weeks. The content of the presentations express the individual opinions of the respective experts.

     

    • Dra. Katia Pagnano, Hemocentro - Universidade de Campinas (UNICAMP), Campinas, SP (Brazil)
    • Prof. Dr. Marcio Nucci, Universidade Federal do Rio de Janeiro, RJ (Brazil)
    • Profa Dra. Vaneuza Funke, Universidade Federal do Paraná, Curitiba, SP (Brazil)
     

     

    Flagge BrasilienCOVID-19 vaccines and CML  - perspectives from Brazil
    (in Portuguese)
    incl. Q&A Session


    Program:

    Conversas sobre vacinas para COVID-19 e leucemia mieloide crônica em português

    Junte-se a nós nesse evento, onde especialistas discutirão aspectos importantes das vacinas para COVID-19 e esclarecerão dúvidas sobre as vacinas para COVID-19 em pacientes com LMC.

    1. COVID-19 e leucemia mieloide crônica - experiência brasileira e latino-americana:
      Dra. Katia Pagnano, Hemocentro - Universidade Estadual de Campinas (UNICAMP), Campinas, SP (Brasil)
    2. Visão geral sobre as vacinas contra COVID-19 no Brasil - experiência em pacientes hematológicos e LMC: Prof. Dr. Marcio Nucci, Universidade Federal do Rio de Janeiro, RJ (Brasil)
    3. Vacinas para COVID e transplante de medula óssea na LMC:
      Profa. Dra. Vaneuza Funke, Universidade Federal do Paraná, Curitiba, SP (Brasil)
    4. Q&A (perguntas e respostas)

     

     

     

     

    • Dr Katia Pagnano, Universidade de Campinas, São Paulo (Brazil)
    • Dr Ana Carolina Toreli, Hospital Brigadeiro, São Paulo (Brazil)
    • Dr Carla Boquimpani, Instituto Estadual de Hematologica Arthur de
      Sigueira Cavalcanti, Rio de Janeiro (Brazil)                                                                     
     

     

    Flagge Brasilien

    CML management during the COVID-19 pandemic – perspectives from Brazil
    (in Portuguese)
    incl. Q&A session

    Watch the webinar to hear experience and perspectives on topics like;

    • Situação atual da COVID no Brasil
    • O que sabemos sobre LMC e COVID

    • Recomendações para o tratamento da LMC durante a pandemia:
      tratamento do paciente recém diagnosticado, pacientes em tratamento
      - necessidade de ajuste de dose/troca/interrupção,
      considerações sobre TFR durante a pandemia

    • Recomendações para o tratamento do paciente com LMC e COVID:
      no recém diagnosticado, necessidade de ajuste de dose/troca/interrupção
      durante a COVID, interações dos TKI com outras drogas
    • Perspectivas futuras: vacinas, tratamentos
    • Dr Jiang Qian, Peking University People’s Hospital, Beijing (China)
    • Dr Xuelin Dou, Peking University People’s Hospital, Beijing (China)

     

     

    Flagge ChinaCML management during the COVID-19 pandemic
    – perspectives from China (in Mandarin)

    incl. Q&A session

    Watch the webinar to hear experience and perspectives on topics like;

    • Patients with hematological malignancies during the SARS-CoV-2 pandemic

    • Patients with chronic myeloid leukemia during the SARS-CoV-2 pandemic

    • CML treatment recommendations for patients without COVID-19 during the SARS-CoV-2 pandemic
    • Dr Elza Lomaia, Almazov National Medical Research Centre, St. Petersburg
      (Russian Federation)
    • Dr Jurii Osipov, Almazov National Medical Research Centre, St. Petersburg
      (Russian Federation)
    • Dr Ekaterina Chelysheva, National Research Centre for Hematology, Moscow
      (Russian Federation)
     

     

    Flagge RusslandCML management during the COVID-19 pandemic
    – perspectives from Russia
    (in Russian)
    incl. Q&A session

    Watch the webinar to hear experience and perspectives on topics like;

    • CML treatment recommendations for patients without COVID-19
      including therapy initiation / therapy switch / monitoring / new trials and drugs for CML
    • The optimal strategy for prevention of COVID-19 and management
      of COVID-19 patients
    • Recommendations for treating patients with CML and COVID-19
      including therapy initiation / therapy switch / therapy stopping /
      any interaction with COVID-19 treatment / TFR

     

     

     

     

    • Dr Carolina Pavlovsky, Fundaleu Hospital and Clinical Research Center Buenos Aires (Argentina)
    • Dr Beatriz Moiraghi, Hospital Ramos Mejía, Buenos Aires, Argentina
    • Dr Virginia Abello Polo, Clínica del Country / Fundación Universitaria de Ciencias de la Salud, Bogotá (Colombia)
       

     

    Flagge ArgentinienCML management during the COVID-19 pandemic
    – perspectives from Argentina and Colombia
    (in Spanish)
    incl. Q&A session

    Watch the webinar to hear experience and perspectives on topics like;

    • Situación actual en ArgentinaFlagge Kolumbien
    • Situación actual en Colombia.
    • Recomendaciones para el tratamiento de los pacientes con LMC y COVID-19
      • Decisiones de tratamiento
      • Aspectos sobre el monitorio
      • Evento adverso
      • Discontinuación de tratamiento